Cargando…
The Evolving Regulatory Landscape for Fentanyl: China, India, and Global Drug Governance
The rise of the synthetic opioid epidemic has time and time again brought criticism on China and India, the world’s two main producers of fentanyl and its chemical precursors. In the past few years, the two countries have attempted to strengthen regulations over fentanyl production and distribution,...
Autores principales: | Wang, Chao, Lassi, Nicholas, Zhang, Xiaohan, Sharma, Vinay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871795/ https://www.ncbi.nlm.nih.gov/pubmed/35206258 http://dx.doi.org/10.3390/ijerph19042074 |
Ejemplares similares
-
Combating illicit fentanyl: Will increased Chinese regulation generate a public health crisis in India?
por: Wang, Chao, et al.
Publicado: (2022) -
Evolving drug regulatory landscape in China: A clinical pharmacology perspective
por: Tang, Weifeng, et al.
Publicado: (2021) -
Strengthening pill press control to combat fentanyl: Legislative and law enforcement imperatives
por: Lassi, Nicholas
Publicado: (2023) -
Evolving Landscape of Multiple Sclerosis in India: Challenges in the Management
por: Kumar, Sudhir, et al.
Publicado: (2018) -
Clinical trials and evolving regulatory science in India
por: Gupta, Y. K., et al.
Publicado: (2014)